Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema

NCT02670720 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped preceding efficacy study of avoralstat in its current formulation was not significant and does not support continued development

Conditions

Interventions

Sponsor

BioCryst Pharmaceuticals